Visante’s Top 10 Issues in Pharmacy in 2023 for Health Care Providers

SPONSORED CONTENT

We are pleased to again bring you Visante’s Top 10 issues in pharmacy for 2023. For 2022, our Top 10 items (Pharmacy Org Structure, 340B Program, Vertical Integration & Marketplace Restrictions, Drug Prices & Supply Chain, Infusion Services, Drug Shortages, Pandemic, Economy, Election, Social Justice)

Read More »

Keep 340B Strong, AHA Says in Wall Street Journal Ad

AHA advertisement
The American Hospital Association's ad in The Wall Street Journal said, “It is in the best interest of all to keep the 340B program strong.”

The American Hospital Association purchased a large ad in The Wall Street Journal print edition Tuesday touting the 340B program’s benefits and saying, “It is in the best interest of all to keep the 340B program strong.”

The quarter-page

Read More »

Health System Makes Improvements at 340B Hospital in New York Times Investigation

Richmond Community Hospital building and signage
Bon Secours Health System opened a long-delayed medical office building adjacent to the Richmond, Va., hospital that was the focus of a New York Times investigation of alleged 340B program misuse.

An Ohio-based health system that was the focus of a New York Times investigation of alleged 340B program misuse opened a long-delayed medical office building this week near the Richmond, Va., hospital featured in the exposé.

Bon Secours Health System

Read More »

CMS Announces Medicare Drug Price Negotiation Dates

Screenshot of Newsroom Medicare Drug Price Negotiation story
CMS will publish the first 10 Medicare Part D drugs selected for the new Medicare Drug Price Negotiation Program by Sept. 1.

The U.S. Centers for Medicare & Medicaid Services will publish the first 10 Medicare Part D drugs selected for the new Medicare Drug Price Negotiation Program by Sept. 1, CMS announced yesterday.

The negotiated maximum fair prices for these drugs

Read More »

Breaking: Judge Declines to Order HHS to Promptly Repay 340B Hospitals for Illegal Medicare Part B Drug Reimbursement Cuts

USDC Washington, D.C. court house building
A federal district court in Washington, D.C., declined to order HHS to promptly repay hospitals for illegal Part B drug payment cuts spanning five years.

A federal district judge in Washington, D.C., this morning ruled that Medicare Part B underpayments to hospitals for 340B drugs from 2018 to 2022 were unlawful. But in a disappointment for the hospital groups that sued, the judge declined to

Read More »

U.S. District Court Orders 340B Report to Destroy and Not Divulge Legally Obtained Information in 340B Patient Definition Case

Screenshot of District of South Carolina Genesis Health Care Inc. v. Becerra et al court order
A federal district court ordered 340B Report to destroy and not divulge the contents of legally obtained records filed by the federal government in a lawsuit over the 340B patient definition.

A federal district court in South Carolina ordered 340B Report late yesterday to destroy and not release information from more than 9,000 pages of documents that the federal government filed in a public database Thursday in a community health center’s

Read More »

Congressional Committee Lineups Still in Flux After McCarthy Installed as House Speaker

House Speaker Kevin McCarthy in the speaker's chair
U.S. Rep. Kevin McCarthy (R-Calif.) takes the podium Jan. 7 after being elected as House Speaker.

The members, GOP chairs, and top-ranking Democrats of U.S. House committees for the 118th Congress still had not been formally announced this morning, three days after Republicans chose Rep. Kevin McCarthy (R-Calif.) to be House speaker.

It took four days

Read More »

340B “Overdue for Reform,” Industry Trade Group BIO Says in Blog

Screenshot of bionews.com 340B drug discount program story
The 340B program “is buckling under its own weight and overdue for reform,” BIO says in its blog.

The 340B program “is buckling under its own weight and overdue for reform,” biotechnology industry trade group BIO said last week in its blog.

BIO, which is marking its 30th anniversary in 2023, has experienced inner turmoil in recent

Read More »

CMS Plans in April to Address Potential Remedies for Illegal Drug Payment Cuts for 340B Hospitals

Screenshot of CMS meeting agenda
CMS plans to issue a proposed rule in April regarding “potential remedies” for illegal Part B drug payment cuts for 340B hospitals from 2018 through late September 2022.

Federal Medicare officials plan to issue a proposed rule in April regarding “potential remedies” for illegal Part B drug payment cuts for 340B hospitals from 2018 through late September 2022.

The Centers for Medicare & Medicaid Services revealed April as

Read More »

340B Provider Ally Stabenow Will Not Seek Re-Election to U.S. Senate in 2024

Sen. Debbie Stabenow (D-MI) headshot
U.S. Sen. Debbie Stabenow (D-Mich.) will not seek re-election in 2024, depriving 340B covered entities of a reliable ally.

U.S. Sen. Debbie Stabenow (D-Mich.) will not seek re-election in 2024, a decision that will deprive 340B covered entities of a reliable ally in Congress.

Stabenow issued a statement yesterday announcing her decision. She was one of six senators—three

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live